Fintel reports that on April 9, 2025, HC Wainwright & Co. initiated coverage of vTv Therapeutics (NasdaqCM:VTVT) with a Buy ...

Fintel reports that on April 9, 2025, HC Wainwright & Co. downgraded their outlook for Rallybio (NasdaqGS:RLYB) from Buy to ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

Stock analysts at HC Wainwright boosted their Q3 2025 earnings per share (EPS) estimates for shares of Alnylam ...

Across the recent three months, 5 analysts have shared their insights on Personalis PSNL -12.7% Get Free Report , expressing ...

Investment analysts at HC Wainwright issued their Q1 2025 earnings estimates for Ryvyl in a research report issued to clients and investors on Thursday, April 3rd. HC Wainwright analyst K. Dede ...

H.C. Wainwright analyst Joseph Pantginis maintained a Hold rating on Xenetic Biosciences (XBIO – Research Report) today. The company’s shares ...

Legend Biotech's Carvykti shows strong efficacy in multiple myeloma as U.S.-based manufacturing shields it from tariffs and global regulatory risks.

Oncolytics Biotech Inc shares T.ONC are trading unchanged at $0.74.

H.C. Wainwright raised the firm’s price target on FTC Solar (FTCI) to $5 from $1.50 and keeps a Buy rating on the shares following the 1-for-10 ...

We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at ...

H.C. Wainwright analyst Patrick Trucchio initiated coverage of Alto Neuroscience (ANRO) with a Buy rating and $10 price ...